Cell Source, Inc. (CLCS): Operating Income

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2019-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$3.84M
Year ended 2024-12-31
2017-12-31: -$2.29M2018-12-31: -$2.01M2019-12-31: -$3.81M2020-12-31: -$3.64M2021-12-31: -$4.02M2022-12-31: -$4.18M2023-12-31: -$4.33M2024-12-31: -$3.84M-$3.84M
2017-12-31 Operating Income (USD) 2024-12-31
Period endedOperating IncomeChange YoYSource filing
2024-12-31-$3.84Mn/m2026-04-07, From 2024-01-01
2023-12-31-$4.33Mn/m2026-04-07, From 2023-01-01
2022-12-31-$4.18Mn/m2024-06-24, From 2022-01-01
2021-12-31-$4.02Mn/m2023-08-08, From 2021-01-01
2020-12-31-$3.64Mn/m2022-04-15, From 2020-01-01
2019-12-31-$3.81Mn/c2021-04-15, From 2019-01-01
2018-12-31-$2.01Mn/m2020-03-30, From 2018-01-01
2017-12-31-$2.29Mn/a2019-04-01, From 2017-01-01